1.Study on the expressions of Pgp,GST-?,Topo Ⅱ and their relationship with p16 and p53 in gastric carcinoma
Journal of Medical Postgraduates 2003;0(10):-
0.05),but the positive degrees were distinctly different(P0.05). Conclusion:The status of p53 may be related with multidrug resistance and the p53 positive tumors possibly show low sensitivity to chemotherapy.
4.Clinical study of recombinant human endostatin with GP regimen in the treatment of advanced non-small-cell lung cancer
Ming GU ; Limin GENG ; Hongyi SUN
Cancer Research and Clinic 2011;23(10):690-692
Objective To evaluate the efficacy and security of combined recombinant human endostatin with GP chemotherapy for the treatment of advanced non-small-cell lung cancer (NSCLC).Methods Non- randomized concurrent control was used.32 patients were treated by recombinant human endostatin combined with chemotherapy as test group,40 patients of control group only received chemotherapy.The response rate (RR),the clinical benefit rate (CBR) and the time to progression (TTP) were observed.Results The total RR in two groups were 40.6 % and 20.0 % (x2 =3.66,P =0.07).The total CBR were 68.8 % and 42.5 % (x2 =4.93,P =0.034).The total time to progression were 5.2 months and 3.9 months (P =0.042).Incidence of adverse reactions of experimental group and control group was no significant difference.Conclusion Combined recombinant human endostatin and chemotherapy can improve the curative effect (RR,CBR and TTP) of advanced NSCLC.
5.Influences of sulfated polysaccharide from pine (Pinus massoniana) pollen on the regulation of [ Ca2+] i in T lymphocytes
Chinese Pharmacological Bulletin 2014;(8):1151-1155
Aim Tostudytheinfluencesofsulfated polysaccharides ( SPPM60-D) on the regulation of free calcium concentration ( [ Ca2+] i ) of T lymphocytes of mice in vitro and explore the mechanisms involved. Methods Polysaccharides(PPM60)wereextracted from masson pine pollen with hot water and 60% etha-nol. PPM60-D was separated and purified from PPM60 with Sephacryl S-400HR. Sulfated polysaccharides ( SPPM60-D ) were derivated by chlorosulfonic acid-pyridine method and the [ Ca2+] i of T lymphocytes were measured by fluorescence spectrophotometer. IL-2 and IL-4 were measured by ELISA kits. Results ConAandSPPM60-Dcouldincrease[Ca2+]iinT lymphocytes by 211. 5% and 201. 8% respectively ( P<0. 01). 2-APB, LY294002, U73122 and verapamil rather than TAK-242 could significantly inhibit the in-crease of [ Ca2+] i induced by SPPM60-D. SPPM60-D could significantly increase the level of IL-2 and IL-4 in supernatant ( P <0. 01 ) . 2-APB rather than TAK-242 could significantly inhibit the increase of cyto-kines.Conclusion ItisspeculatedthatSPPM60-D could increase [ Ca2+ ] i via TCR/CD3-PI3K-PLC-IP3 R-Ca2+ signal pathway through TCD/CD3 receptor in T lymphocytes so that it could improve the level of IL-2 and IL-4 in supernatant in T lymphocytes.
6.Changes of ACTH level to hypoxia in rat.
Hai-hong ZHU ; Ming ZHAO ; Pai-li GENG
Chinese Journal of Applied Physiology 2005;21(1):72-73
Adrenocorticotropic Hormone
;
blood
;
Animals
;
Female
;
Hypoxia
;
metabolism
;
Male
;
Rats
;
Rats, Wistar
7.Significance of melanocytes in diagnosis of congenital and acquired cholesteatoma.
Geng-Ming CAI ; Zhi-Chun LI ; Zi-Xiang YI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2007;42(2):147-148
Adolescent
;
Adult
;
Aged
;
Cholesteatoma, Middle Ear
;
congenital
;
pathology
;
Female
;
Humans
;
Male
;
Melanocytes
;
Middle Aged
;
Young Adult
8.The relationship between the plasma concentration of urotension II (U II) and NO, NOS in spontaneous hypertensive rats and influence of candesartan.
Shu-huai BIAN ; Ming-yue YU ; Qiang GENG
Chinese Journal of Applied Physiology 2009;25(2):194-263
Angiotensin II Type 1 Receptor Blockers
;
therapeutic use
;
Animals
;
Benzimidazoles
;
therapeutic use
;
Hypertension
;
blood
;
drug therapy
;
Male
;
Nitric Oxide
;
blood
;
Nitric Oxide Synthase Type III
;
blood
;
Random Allocation
;
Rats
;
Rats, Inbred SHR
;
Tetrazoles
;
therapeutic use
;
Urotensins
;
blood
9.Mouse nerve growth factor and sub-hypothermia for neural protection in severe traumatic brain injury and its mechanism
Ming LI ; Jihong YANG ; Weifeng GENG ; Na LI ; Zhichang ZHENG
Chinese Journal of Biochemical Pharmaceutics 2017;37(1):129-132
Objective To investigate the mechanism of neural protection of mouse nerve growth factor combined with sub-hypothermia in the treatment of patients with severe traumatic brain injury. Methods 90 cases of severe traumatic brain injury were randomly divided into study group and control group with 45 cases of each group, the control group were given routine treatment; the study group were given on the basis of routine treatment of mouse nerve growth factor combined with sub-hypothermia treatment, with 2 weeks treatment, the clinical indicators and corresponding nerve injury, inflammation, oxidative stress indexes, clinical effect and complications were compared after 2 weeks treatment. Results Compared with before treatment or control group, scores of Glasgow coma scale (GCS) and Glasgow outcome scale (GOS) and montreal cognitive assessment (MoCA) in study group after the treatment increased, National Institute of Health stroke scale (NIHSS) score decreased(P<0.05), neuronspecific enolase (NSE), myelin basic protein (MBP) and S100 beta levels decreased(P<0.05), the serum tumor necrosis factor-α (TNF-α),interleukin-6 (IL-6), IL-10 levels decreased (P<0.05), the malondialdehyde (MDA) decreased, the glutathione peroxidase (GPx) and oxidation resistance (AOA) levels increased (P<0.05). The control group efficiency was 73.33%, the study group efficiency was 91.11%, there was significant difference (P<0.05). All patients were followed up, no case off, there was no significant difference in adverse drug reaction rate between two groups. Conclusion Mouse nerve growth factor and sub-hypothermia has the significant neural protection for patients with severe traumatic brain injury, and its mechanism may be related to reduce nerve injury indicators and improve inflammatory factor and oxidative stress response.
10.Diagnosis and treatment of hilar cholangiocarcinoma
Ming GAO ; Heping XIANG ; Xiaoping GENG ; Changle ZHANG
Chinese Journal of General Surgery 2001;0(08):-
Objective To improve the level of diagnosis and treatment of hilar cholangiocarcinoma by investgating it′s clinical characteristics.Methods The clinical data of 98 patients with hilar cholangiocarcinoma were analyzed retrospectively.Results According to the Bismuth-Corlitte grouping: typeⅠ,8 cases;typeⅡ,19 cases;type Ⅲ,17 cases;type Ⅲb,14 cases;and type Ⅳ,40 cases.Radical resection(49),palliative operation(12),endoscopic retrograde biliary drainage(16),and PTCD(5) were performed The median survival time of radical resection group was 28.6 months and the survival rate at 1,2,3,and 5 years was 74.2%,65.3%,37.5%,and 3.9% respectively,while the median survival time of palliative operation group was 17.6 months and the survival rate at 1,2,3,and 5 years was 71.7%,26.8%,8.9%,and 0% respectively.The median survival time of endoscopic retrograde biliary drainage group was 4.5 months and the survival rate at 1,2,3,and 5 years was 21%,13%,and 0% respectively.Conclusions Early diagnosis by adjunctive examinations is vital to treatment of hilar cholangiocarcinoma.Radical resection is the sole procedure to improve the outcome and prognosis of hilar cholangiocarcinoma.Multiple therapeutic methods should be adopted and should be individualized.